ATE369425T1 - Antikörper gegen eine lar-phosphatase untereinheit - Google Patents

Antikörper gegen eine lar-phosphatase untereinheit

Info

Publication number
ATE369425T1
ATE369425T1 AT99923958T AT99923958T ATE369425T1 AT E369425 T1 ATE369425 T1 AT E369425T1 AT 99923958 T AT99923958 T AT 99923958T AT 99923958 T AT99923958 T AT 99923958T AT E369425 T1 ATE369425 T1 AT E369425T1
Authority
AT
Austria
Prior art keywords
antibodies
lar
phosphatase subunit
subunit
phosphatase
Prior art date
Application number
AT99923958T
Other languages
English (en)
Inventor
Hiroshi Yamamoto
Kazutake Tsujikawa
Yukiko Uchino
Noboru Konishi
Original Assignee
Fuso Pharmaceutical Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuso Pharmaceutical Ind filed Critical Fuso Pharmaceutical Ind
Application granted granted Critical
Publication of ATE369425T1 publication Critical patent/ATE369425T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT99923958T 1998-06-08 1999-06-07 Antikörper gegen eine lar-phosphatase untereinheit ATE369425T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9802542 1998-06-08

Publications (1)

Publication Number Publication Date
ATE369425T1 true ATE369425T1 (de) 2007-08-15

Family

ID=14208367

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99923958T ATE369425T1 (de) 1998-06-08 1999-06-07 Antikörper gegen eine lar-phosphatase untereinheit

Country Status (9)

Country Link
US (3) US6846912B1 (de)
EP (2) EP1460132A1 (de)
JP (1) JP3991327B2 (de)
KR (1) KR100501550B1 (de)
AT (1) ATE369425T1 (de)
AU (1) AU752642B2 (de)
CA (1) CA2329776C (de)
DE (1) DE69936780T2 (de)
WO (1) WO1999064591A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69939742D1 (de) * 1998-07-10 2008-11-27 Fuso Pharmaceutical Ind Antikörper gegen intrazelluläre domänen der protein tyrosin phosphatase
WO2003005953A2 (en) 2001-07-12 2003-01-23 Immunex Corporation Viral proteins capable of binding lar
GB2403587B (en) * 2002-03-18 2005-08-03 Hitachi Maxell Magnetic recording medium and magnetic recording cartridge
US7622117B2 (en) 2002-04-17 2009-11-24 Dynamis Therapeutics, Inc. 3-deoxyglucosone and skin
WO2006040322A1 (en) * 2004-10-12 2006-04-20 Crucell Holland B.V. Binding molecules for treatment and detection of cancer
US8338109B2 (en) 2006-11-02 2012-12-25 Mayo Foundation For Medical Education And Research Predicting cancer outcome
WO2009100214A2 (en) * 2008-02-05 2009-08-13 The Johns Hopkins University Induction of thyroid iodide-handling gene expression in human cancers
CA2725978A1 (en) 2008-05-28 2009-12-03 Genomedx Biosciences, Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
US9495515B1 (en) 2009-12-09 2016-11-15 Veracyte, Inc. Algorithms for disease diagnostics
US10236078B2 (en) 2008-11-17 2019-03-19 Veracyte, Inc. Methods for processing or analyzing a sample of thyroid tissue
GB2512153B (en) * 2008-11-17 2014-11-12 Veracyte Inc Methods and compositions of molecular profiling for disease diagnostics
US9074258B2 (en) 2009-03-04 2015-07-07 Genomedx Biosciences Inc. Compositions and methods for classifying thyroid nodule disease
JP5392707B2 (ja) * 2009-03-31 2014-01-22 株式会社Ｎｔｔドコモ 膜小胞分裂システム
US9206482B2 (en) 2009-04-29 2015-12-08 Genomedx Biosciences Inc. Systems and methods for expression-based classification of thyroid tissue
US8669057B2 (en) 2009-05-07 2014-03-11 Veracyte, Inc. Methods and compositions for diagnosis of thyroid conditions
US10446272B2 (en) 2009-12-09 2019-10-15 Veracyte, Inc. Methods and compositions for classification of samples
US8313437B1 (en) 2010-06-07 2012-11-20 Suri Jasjit S Vascular ultrasound intima-media thickness (IMT) measurement system
US8639008B2 (en) * 2010-04-20 2014-01-28 Athero Point, LLC Mobile architecture using cloud for data mining application
US8532360B2 (en) 2010-04-20 2013-09-10 Atheropoint Llc Imaging based symptomatic classification using a combination of trace transform, fuzzy technique and multitude of features
US8485975B2 (en) 2010-06-07 2013-07-16 Atheropoint Llc Multi-resolution edge flow approach to vascular ultrasound for intima-media thickness (IMT) measurement
US8708914B2 (en) 2010-06-07 2014-04-29 Atheropoint, LLC Validation embedded segmentation method for vascular ultrasound images
CN103038635B (zh) 2010-05-11 2016-12-28 威拉赛特公司 用于诊断病状的方法和组合物
US20130267443A1 (en) 2010-11-19 2013-10-10 The Regents Of The University Of Michigan ncRNA AND USES THEREOF
US10513737B2 (en) 2011-12-13 2019-12-24 Decipher Biosciences, Inc. Cancer diagnostics using non-coding transcripts
WO2013123097A1 (en) 2012-02-13 2013-08-22 SkyKick, Inc. Migration project automation, e.g., automated selling, planning, migration and configuration of email systems
ES3015226T3 (en) 2012-08-16 2025-04-30 Veracyte Sd Inc Prostate cancer prognosis using biomarkers
BR112015022490A2 (pt) 2013-03-15 2017-07-18 Veracyte Inc métodos e composições para classificação de amostras
US11976329B2 (en) 2013-03-15 2024-05-07 Veracyte, Inc. Methods and systems for detecting usual interstitial pneumonia
US12297505B2 (en) 2014-07-14 2025-05-13 Veracyte, Inc. Algorithms for disease diagnostics
CN114606309A (zh) 2014-11-05 2022-06-10 威拉赛特公司 使用机器学习和高维转录数据的诊断系统和方法
US11414708B2 (en) 2016-08-24 2022-08-16 Decipher Biosciences, Inc. Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
AU2018210695B2 (en) 2017-01-20 2024-07-18 The University Of British Columbia Molecular subtyping, prognosis, and treatment of bladder cancer
WO2018165600A1 (en) 2017-03-09 2018-09-13 Genomedx Biosciences, Inc. Subtyping prostate cancer to predict response to hormone therapy
US11078542B2 (en) 2017-05-12 2021-08-03 Decipher Biosciences, Inc. Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness
WO2018222901A1 (en) 2017-05-31 2018-12-06 Elstar Therapeutics, Inc. Multispecific molecules that bind to myeloproliferative leukemia (mpl) protein and uses thereof
US11217329B1 (en) 2017-06-23 2022-01-04 Veracyte, Inc. Methods and systems for determining biological sample integrity
AU2018310987A1 (en) 2017-08-04 2020-02-27 Decipher Biosciences, Inc. Use of immune cell-specific gene expression for prognosis of prostate cancer and prediction of responsiveness to radiation therapy

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4752583A (en) 1984-11-29 1988-06-21 The United States Of America As Represented By The United States Department Of Energy Monoclonal antibodies to human hemoglobin S and cell lines for the production thereof
US5631151A (en) 1988-10-03 1997-05-20 Biosource Technologies, Inc. Melanin production by transformed organisms
US5888794A (en) 1990-07-11 1999-03-30 New York University Receptor-type phosphotyrosine phosphatase-alpha
US5538886A (en) 1990-07-11 1996-07-23 New York University Receptor-type phosphotyrosine phosphatase-alpha
US5480972A (en) 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
UA58482C2 (uk) 1994-06-08 2003-08-15 Бьорінгер Інгельхайм Інтернаціональ Гмбх Моноклональне антитіло vff-18 проти сd44v6 і його фрагменти
US5646333A (en) 1994-09-02 1997-07-08 Drexel University Plant promoter useful for directing the expression of foreign proteins to the plant epidermis
DE69939742D1 (de) * 1998-07-10 2008-11-27 Fuso Pharmaceutical Ind Antikörper gegen intrazelluläre domänen der protein tyrosin phosphatase

Also Published As

Publication number Publication date
EP1092772A4 (de) 2004-07-07
EP1460132A1 (de) 2004-09-22
US20050042222A1 (en) 2005-02-24
US20050008645A1 (en) 2005-01-13
EP1092772B1 (de) 2007-08-08
CA2329776A1 (en) 1999-12-16
KR100501550B1 (ko) 2005-07-18
US20050026232A1 (en) 2005-02-03
KR20010052712A (ko) 2001-06-25
DE69936780T2 (de) 2008-06-05
DE69936780D1 (de) 2007-09-20
AU4060399A (en) 1999-12-30
CA2329776C (en) 2009-02-10
US7358061B2 (en) 2008-04-15
JP3991327B2 (ja) 2007-10-17
WO1999064591A1 (en) 1999-12-16
AU752642B2 (en) 2002-09-26
US6846912B1 (en) 2005-01-25
EP1092772A1 (de) 2001-04-18

Similar Documents

Publication Publication Date Title
DE69936780D1 (de) Antikörper gegen eine lar-phosphatase untereinheit
NO20021701L (no) Fremgangsmåte for fremstilling av et konjugat av polyglutamat og et terapeutisk middel
TR199902803T2 (xx) VCAM-1' in te�hisinin daralt�lmas� i�in bile�ikler ve metodlar.
DE3751809D1 (de) Intraoperative erstellung des befundes und tumor-therapie mittels endoskop
DE69907154D1 (de) Krebsbehandlung
BR9912007A (pt) Composições e métodos para terapia e diagnóstico de câncer de próstata
ATE517125T1 (de) ANTIKÖRPER GEGEN ßDEATH RECEPTOR 4ß (DR4) UND DEREN VERWENDUNGEN
AU2003205077A1 (en) Imaging agents and methods of imaging naaladase of psma
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
BR0012069A (pt) Composições e métodos para a terapia e diagnóstico de câncer pulmonar
CY1116265T1 (el) Kit ραδιοεπισημανσης και προσδιορισμος δεσμευσης
DE60220719D1 (de) Antikörper gegen das muc18-antigen
WO2004031411A3 (en) Genes and polypeptides relating to human pancreatic cancers
WO2005086612A3 (en) Fluorinated carbohydrate conjugates
MXPA04000080A (es) Metodos de diagnostico de cancer en la vejiga, composiciones y metodos de rastreo de moduladores de cancer en la vejiga.
BR0009537A (pt) Composições para tratamento e diagnóstico de câncer de mama e métodos para seu uso
ATE394121T1 (de) Verwendung von antikörpern gegen das muc18- antigen
ATE400587T1 (de) Gegen das prostata-stammzellantigen (psca) gerichtete antikörper und deren verwendung
EP1409544A4 (de) Humane dr4-antikörper und deren anwendungen
ATE423191T1 (de) Prostata stammzellantigen (psca) und dessen verwendungen
NO331101B1 (no) In vitro-fremgangsmate for a uttrykke et antigenmolekyl og antigenmolekyl og et fotosensibiliserende middel for anvendelse ved uttrykking av antigenmolekylet.
CY1109125T1 (el) Θεραπευτικα και διαγνωστικα anti-hsp 70 αντισωματα
IL146125A0 (en) Novel quinones as disease therapies
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
EP1605847A4 (de) Gegen antikörper gerichtete photodynamische therapie

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties